CClinicalTrials.gg
CompletedNCT06198283Updated Jan 30, 2024

Effects of Pressure Garments on Hypertrophic Hand Scar in Burn Children

An interventional study of Low Level LASER Therapy with Pressure Garment and Low Level LASER Therapy without Pressure Garment in Burns Laser, sponsored by Riphah International University. Completed at 1 site in Pakistan. Open to participants aged 2 Years to 10 Years. Per ClinicalTrials.gov, last updated 2024-01-30.

Sponsored by Riphah International University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
2 Years to 10 Years
Sex
All
01

Study summary

Burns are type of injury that affect the skin or other tissues and are typically caused by acute trauma, including thermal sources, electricity, chemicals, friction, or radiation. Thermal burns are frequently caused by exposure to high temperature solids or liquids, as well as flames. The epidermis is the only layer of skin affected by superficial burns (sometimes known as "first degree" burns). Blistering is a common symptom of partial thickness (second degree) burns, which damage both the epidermis and dermis.

Read the detailed description

This study will include patients with age 2-10 \& having burns on hands and develop scars will be recruited through Randomized Controlled trial in which convenience sampling technique will be used. Two groups will be formed in which participants will be divided by lottery method. Group A which will be treated by low level laser therapy with pressure garment (8-10hrs a day) and group B which will receive low level LASER therapy (422-800nm) without pressure garment only for the duration of 6 weeks (3 days in a week with 20-30 minutes per session). Vancouver Scar Scale and PSOAS tool will be used. The result after statistical analysis will either show both treatments equally effective or not. Data will be calculated before and after treatment with the help of outcome measure tools. Results will be analyzed on SPSS.

02

Conditions studied

  • Burns Laser

Browse trials for

Keywords

  • Burn scar, Hypertrophy Scar
  • Pressure garment,
  • Low level laser,
03

In context

Burns

719 studies on the registry are indexed under Burns; 145 are open to participants now.

This study's enrollment of 26 is below the median of 40 across 524 interventional studies indexed under Burns.

Browse Burns studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,133 studies on the registry; 633 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 2-10 years
  • Patient with 2nd degree of burns on hands and develop scar
  • Patients after 3 months of burn on hand
  • Only patients that were diagnosed with hypertrophic scars secondary to burn injuries were included
  • Patients those with second degree burns or more or those with HS from burns
  • Scar type (hypertrophic, flat or atrophic) and scar dyschromia (i.e. erythema) are the main factors that drive laser device selection

Exclusion criteria

Exclusion Criteria:

  • Participants who have certain medical problems that may impair scar healing or response to therapy interventions (such as uncontrolled diabetes, autoimmune disorders, or immunocompromised states).
  • Those who have suffered burns recently (within the past few weeks) or who have had their scars for a long time (five years or more)
  • Wounds that have open area and risk of bleeding occurs.
  • Any spinal cord injuries.
  • Patients with any other skin disease like skin cancer, inflammation,Allergic conditions etc
  • Patients with under treatment like radiations etc
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
26 participants (actual)

Study arms

  • Experimental
    Group A

    This group will be treated by low level laser therapy with pressure garments

    Other: Low Level LASER Therapy with Pressure Garment

  • Active comparator
    Group B

    This group will receive low level LASER therapy without pressure garment

    Other: Low Level LASER Therapy without Pressure Garment

Interventions

  • OtherLow Level LASER Therapy with Pressure Garment

    This group will be treated by low level laser therapy with pressure garment (8-10hrs a day) by Laplace' s Law method because it is more accurate since the range of pressures that can be delivered to a particular range of body circumferences varies depending on the fabric used and its particular tension- extension profile, the method is difficult to utilize manually and till present there is no available design tool to aid in its application. Pressure garments generate an increase in subdermal pressures in the range 9- 90 mmHg depending on the anatomical site. Garments over soft tissues generate pressures ranging from 9 to 33 mmHg. Over bony prominences the pressures range from 47 to 90 mmHg. 25mmHg pressure will be provided by garments and garments will be replaced in every 2 months

  • OtherLow Level LASER Therapy without Pressure Garment

    This group will receive low level LASER therapy (422-800nm) without pressure garment only for the duration of 6 weeks (3 days in a week with 20-30 minutes per session).

06

What researchers measure

Primary outcomes

  1. Patient and observer Scar Assessment scale (POSAS)

    The patient and observer scar evaluation scale (POSAS) was developed to objectively grade different scars based on the opinions of both the patient and an observer. The ease of use and comprehensive information it delivers make this instrument preferable to others. It was applied to the assessment of burn scars and linear surgical scars, with results that were both reliable and valid.Predictive validity was considered excellent with a AUC of 0.9, good from 0.8 to 0.899, adequate from 0.7 to 0.799 and poor when \<0.7. A scale is considered internally consistent with a Cronbach' s alpha from0.70 to 0.90. For ICCs a minimum value of 0.70 was considered as an acceptable reliable result.

    Time frame: 6 weeks

  2. Vancouver Scar Scale VSS

    The Vancouver Scar Scale (VSS), formerly called the Burn Scar Index, is the most used objective scar grading system. It was created in 1990. The VSS has a total score out of 13, broken down into four categories: pigmentation, vascularity, pliability, and scar height. The VSS isn't perfect because it doesn't take into account the patient's perspective, is subject to operator- dependent errors, leaves out discomfort and pruritis, and doesn't hold anyone responsible for huge scars with uneven coloration. Nonetheless, because of its intended use in assessing burn scars, it has become the most popular and widely-used scale of its kind.

    Time frame: 6 weeks

07

Study locations

1 site
  • Riphah International University
    Lahore, Punjab 54000, Pakistan
08

References and documents

Publications

  • Noorbakhsh SI, Bonar EM, Polinski R, Amin MS. Educational Case: Burn Injury-Pathophysiology, Classification, and Treatment. Acad Pathol. 2021 Nov 28;8:23742895211057239. doi: 10.1177/23742895211057239. eCollection 2021 Jan-Dec. PubMed 34869832 ↗
  • Alnababtah K, Khan S, Ashford R. Socio-demographic factors and the prevalence of burns in children: an overview of the literature. Paediatr Int Child Health. 2016 Feb;36(1):45-51. doi: 10.1179/2046905514Y.0000000157. Epub 2014 Oct 13. PubMed 25309999 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 30, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06198283
Lead sponsor
Riphah International University
Responsible party
Sponsor
First posted
Jan 10, 2024
Start date
Nov 28, 2023
Primary completion
Dec 31, 2023
Completion
Jan 15, 2024
Last update
Jan 30, 2024

Study contacts

Ali Hammad Subhani, MS*
principal investigator · Riphah International University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion